ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

ASCO 2026: Comment: Multi-cancer earlier detection tests

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer

ASCO 2026: Latest updates in mRCC

Part 1: Why test?

Part 2: How to get biopsies for testing?

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

ctDNA predicts early treatment response in HPV-associated anal cancer

mCRPC treatment sequencing: Need for optimal therapy at the earliest opportunity